142 related articles for article (PubMed ID: 22493349)
1. 5-aminosalicylic acid mediates expression of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase to suppress colorectal tumorigenesis.
Miyoshi J; Yajima T; Shimamura K; Matsuoka K; Okamoto S; Higuchi H; Funakoshi S; Takaishi H; Hibi T
Anticancer Res; 2012 Apr; 32(4):1193-202. PubMed ID: 22493349
[TBL] [Abstract][Full Text] [Related]
2. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
Moore AE; Greenhough A; Roberts HR; Hicks DJ; Patsos HA; Williams AC; Paraskeva C
Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428
[TBL] [Abstract][Full Text] [Related]
3. Renal localization and regulation of 15-hydroxyprostaglandin dehydrogenase.
Yao B; Xu J; Harris RC; Zhang MZ
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F433-9. PubMed ID: 18057186
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase.
Wakimoto N; Wolf I; Yin D; O'Kelly J; Akagi T; Abramovitz L; Black KL; Tai HH; Koeffler HP
Cancer Res; 2008 Sep; 68(17):6978-86. PubMed ID: 18757412
[TBL] [Abstract][Full Text] [Related]
5. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P
Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207
[TBL] [Abstract][Full Text] [Related]
6. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.
Ding Y; Tong M; Liu S; Moscow JA; Tai HH
Carcinogenesis; 2005 Jan; 26(1):65-72. PubMed ID: 15358636
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid.
Stolfi C; Fina D; Caruso R; Caprioli F; Sarra M; Fantini MC; Rizzo A; Pallone F; Monteleone G
Biochem Pharmacol; 2008 Feb; 75(3):668-76. PubMed ID: 17981262
[TBL] [Abstract][Full Text] [Related]
8. Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.
Liu Z; Wang X; Lu Y; Han S; Zhang F; Zhai H; Lei T; Liang J; Wang J; Wu K; Fan D
Carcinogenesis; 2008 Jun; 29(6):1219-27. PubMed ID: 18174234
[TBL] [Abstract][Full Text] [Related]
9. Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene.
Li M; Xie J; Cheng L; Chang B; Wang Y; Lan X; Zhang D; Yin Y; Cheng N
Cancer Invest; 2008 Nov; 26(9):905-12. PubMed ID: 19034772
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin catabolic enzymes as tumor suppressors.
Tai HH
Cancer Metastasis Rev; 2011 Dec; 30(3-4):409-17. PubMed ID: 22020925
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.
Tong M; Ding Y; Tai HH
Carcinogenesis; 2006 Nov; 27(11):2170-9. PubMed ID: 16632868
[TBL] [Abstract][Full Text] [Related]
12. Expression of prostaglandin metabolising enzymes COX-2 and 15-PGDH and VDR in human granulosa cells.
Thill M; Becker S; Fischer D; Cordes T; Hornemann A; Diedrich K; Salehin D; Friedrich M
Anticancer Res; 2009 Sep; 29(9):3611-8. PubMed ID: 19667156
[TBL] [Abstract][Full Text] [Related]
13. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin metabolizing enzymes in correlation with vitamin D receptor in benign and malignant breast cell lines.
Thill M; Fischer D; Becker S; Cordes T; Dittmer C; Diedrich K; Salehin D; Friedrich M
Anticancer Res; 2009 Sep; 29(9):3619-25. PubMed ID: 19667157
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 knockdown by RNA interference in colon cancer.
Charames GS; Bapat B
Int J Oncol; 2006 Feb; 28(2):543-9. PubMed ID: 16391811
[TBL] [Abstract][Full Text] [Related]
16. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer.
Backlund MG; Mann JR; Holla VR; Buchanan FG; Tai HH; Musiek ES; Milne GL; Katkuri S; DuBois RN
J Biol Chem; 2005 Feb; 280(5):3217-23. PubMed ID: 15542609
[TBL] [Abstract][Full Text] [Related]
17. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer.
Monteleone NJ; Moore AE; Iacona JR; Lutz CS; Dixon DA
Sci Rep; 2019 Apr; 9(1):5405. PubMed ID: 30931980
[TBL] [Abstract][Full Text] [Related]
18. 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells.
Chi X; Freeman BM; Tong M; Zhao Y; Tai HH
Arch Biochem Biophys; 2009 Jul; 487(2):139-45. PubMed ID: 19501039
[TBL] [Abstract][Full Text] [Related]
19. Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of toll-like receptor 4.
Wang H; Hirsch E
Biol Reprod; 2003 Dec; 69(6):1957-63. PubMed ID: 12904319
[TBL] [Abstract][Full Text] [Related]
20. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
